Eli Lilly reports mixed earnings, increases 2025 guidance
Eli Lilly reported fourth quarter and full year earnings for 2024 Thursday, with results largely beating Wall Street ...
McKesson’s Broad-Based Growth Is Fueled by GLP-1s, New Customers, and a Growing Specialty Portfolio
Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...
Eli Lilly records over twofold rise in diabetes/ obesity drugs in Q4
EST: Adds comments from Seeking Alpha analyst BioCGT Investor Eli Lilly (NYSE:LLY) on Thursday reported its Q4 2024 results, exceeding Wall Street forecasts and indicating a more than twofold rise in ...